DefinitionThis section has been translated automatically.
CIM is the acronym for: CTLA-4-Ig costimulation modulator. This term refers to a group that selectively boosts the CD28-mediated co-stimulation of naïve T lymphocytes. To date, abatacept is the only drug of this active group approved on the market that can be used to treat autoimmune diseases.
